0102030405
CAS No.571188-82-4 Pharmaceutical Intermediates
02
introduce
Palbociclib intermediates are key compounds in the synthesis of Palbociclib, a targeted therapy for certain types of breast cancer. They play a vital role in the pharmaceutical industry, especially in the development of innovative cancer therapeutics. Our products are manufactured in state-of-the-art facilities and follow the highest quality standards to ensure their effectiveness and safety.
02
Physical and chemical properties
Palbociclib intermediates have unique physical and chemical properties that contribute to their efficacy in pharmaceutical applications.
- Molecular formula: C27H34BrN7O3
- Molecular weight: 584.51 g/mol
- Appearance: The product is usually white powder, indicating its high purity.
- Solubility: It is soluble in organic solvents such as DMSO and methanol, and can be easily incorporated into various formulations.
- Stability: The compound exhibits excellent stability under standard storage conditions, ensuring longer shelf life and production reliability.
These properties make Palbociclib intermediates ideal for pharmaceutical companies seeking to develop high-quality cancer therapeutics.
1. Enhanced efficacy: The high purity of our Palbociclib intermediates ensures that the final product can effectively inhibit cancer cell proliferation and provide better treatment effects for patients.
2. Streamlined Production: Our integrated production process enables efficient manufacturing, reduces lead times and ensures our customers receive their orders in a timely manner.
3. Regulatory Compliance: We adhere to international quality standards and regulations, assuring our customers that our products are safe and qualified for pharmaceutical applications.
4. Customized Solutions: We understand that each customer has unique needs. Therefore, we provide customized solutions and formulations to meet specific requirements, thereby enhancing the overall value of our products.
5. Commitment to Sustainability: Our manufacturing processes are designed with sustainability in mind, minimizing waste and environmental impact while maintaining high quality production standards.
Palbociclib intermediates are primarily used to synthesize Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This mechanism of action is critical for the treatment of hormone receptor-positive breast cancer, especially in patients with advanced or metastatic disease.
The pharmaceutical industry relies on high-quality intermediates like Palbociclib to ensure the efficacy and safety of final products. By choosing our products, pharmaceutical manufacturers can enhance their research and development efforts to create innovative therapies that improve patient outcomes.
In summary, our Palbociclib intermediates are high-quality, reliable, and cost-effective solutions for pharmaceutical companies engaged in cancer research and drug development. With our commitment to quality, sustainability, and customer support, we are dedicated to helping our customers succeed. Choose our Palbociclib intermediates for your pharmaceutical needs and experience the difference in quality and service.
For more information or to place an order, contact us today!